Free Radical Biology and Medicine · 2025 · 11 citations · 50 references
Life SciencesGeneticsOphthalmologyCellular MetabolismMitochondrial BiologyOcular DiseaseGlaucomaMitochondrial DisordersMitochondrial DysfunctionMitochondrial Ocular DisordersMitochondrial PhysiologyMitophagyCristae MorphologyExfoliation SyndromeMitochondrial Biogenesis DefectsMitochondrial Biogenesis In NeurodegenerationMitochondrial Disease PathologyMitochondrial Dna DeletionsMitochondrial Genome DeletionsMitophagy Impairment
Exfoliation Syndrome is an age-related systemic condition characterized by large aggregated fibrillar material deposition in the anterior eye tissues. This aggregate formation and deposition on the aqueous humor outflow pathway are significant risk factors for developing Exfoliation Glaucoma (XFG). XFG is a multifactorial late-onset disease that shares common features of neurodegenerative diseases, such as increased protein aggregation, impaired protein degradation, and oxidative and cellular stress. XFG patients display decreased mitochondrial membrane potential and mitochondrial DNA deletions. Here, using Tenon Capsule Fibroblasts (TFs) from patients without glaucoma (No Glaucoma, NG) and XFG patients, we found that XFG TFs have impaired mitochondrial bioenergetics and increased reactive oxygen species accumulation. These defects are associated with mitochondrial abnormalities as XFG TFs exhibit smaller mitochondria that contain dysmorphic cristae, with increased mitochondrial localization to lysosomes and slowed mitophagic flux. Mitochondrial dysfunction in the XFG TFs was associated with hyperdynamic microtubules, decreased acetylated tubulin, and increased HDAC6 activity. Treatment of XFG TFs with a mitophagy inducer, Urolithin A (UA), and a mitochondrial biogenesis inducer, Nicotinamide Ribose (NR), improved mitochondrial bioenergetics and reduced ROS accumulation. Our results demonstrate that XFG TFs have abnormal mitochondria and suggest that mitophagy inducers may represent a potential class of therapeutics for reversing mitochondrial dysfunction in XFG patients. • Patient-derived Exfoliation Glaucoma cells are characterized by mitochondrial dysfunction with increased ROS. • Mitochondria from these cells have aberrant morphology with swollen cristae. • Mitophagy flux is impaired leading to a build-up of poor quality mitochondria. • Hyperdynamic and unstable microtubules contribute to defective degradation. • Urolithin A and nicotinamide ribose treatment improve mitochondrial function.
50
HDAC6 is a microtubule-associated deacetylase
Charlotte Hubbert, Amaris R. Guardiola, Rong Shao et al. · Nature · 2002 · 2.4K citations
Robust single-particle tracking in live-cell time-lapse sequences
Khuloud Jaqaman, Dinah Loerke, Marcel Mettlen et al. · Nature Methods · 2008 · 2.1K citations · Full text
Hongbo Zhang, Dongryeol Ryu, Yibo Wu et al. · Science · 2016 · 1.2K citations · Full text
Elastic fiber homeostasis requires lysyl oxidase–like 1 protein
Xiaoqing Liu, Yun Zhao, Jiangang Gao et al. · Nature Genetics · 2004 · 659 citations